Clinical Trials Directory

Trials / Terminated

TerminatedNCT00169026

Alcoholism and Schizophrenia: Effects of Clozapine

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
64 (planned)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
All
Age
19 Years – 65 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to examine the short - term effects of clozapine on alcohol use in persons with schizophrenia and an alcohol use disorder. The hypothesis is that clozapine will have greater efficacy in reducing alcohol use than other antipsychotic medications.

Conditions

Interventions

TypeNameDescription
DRUGClozapine versus typical (conventional) and atypical antipsychotic medications

Timeline

Start date
1999-05-01
Completion
2004-01-01
First posted
2005-09-15
Last updated
2018-03-14

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00169026. Inclusion in this directory is not an endorsement.